2010
DOI: 10.1007/s12307-010-0042-7
|View full text |Cite
|
Sign up to set email alerts
|

Chemokines and Cancer Progression: A Qualitative Review on the Role of Stromal Cell-derived Factor 1-alpha and CXCR4 in Endometrial Cancer

Abstract: The goal of this paper was to examine the literature related to stromal cell-derived factor 1-alpha (SDF-1alpha) and its receptor CXCR4 in endometrial cancer, as expression of these biomarkers has been implicated in an aggressive phenotype in other common epithelial cancers. We conducted a qualitative review of all published studies examining the role of SDF-1alpha/CXCR4 in endometrial cancer progression and prognosis. Pubmed and Ovid MEDLINE databases were searched in order to identify relevant studies for th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
8
0

Year Published

2011
2011
2022
2022

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(9 citation statements)
references
References 22 publications
1
8
0
Order By: Relevance
“…CXCR4 is a chemokine receptor (C-X-C chemokine receptor type 4), and an increased expression of this receptor has been related to cancer progression 43 44 . Stromal cell-derived factor 1α (SDF-1α) is a natural CXCR4 ligand, and the stimulation of CXCR4 by treatment with SDF-1α induces CXCR4 endocytosis and actin polymerisation 45 46 , leading to macropinocytotic cellular uptake 47 .…”
Section: Resultsmentioning
confidence: 99%
“…CXCR4 is a chemokine receptor (C-X-C chemokine receptor type 4), and an increased expression of this receptor has been related to cancer progression 43 44 . Stromal cell-derived factor 1α (SDF-1α) is a natural CXCR4 ligand, and the stimulation of CXCR4 by treatment with SDF-1α induces CXCR4 endocytosis and actin polymerisation 45 46 , leading to macropinocytotic cellular uptake 47 .…”
Section: Resultsmentioning
confidence: 99%
“…Especially in breast cancer, microarray analysis identified CXCR4 as one of critical genes that was enriched in metastasis breast tumor cells, and overexpression of CXCR4 alone significantly increased the chance of metastasis in lung tissue and bone tissue shown in in vivo test and clinical study [reviewed in (Felix et al, 2010;Furusato et al, 2010;Wendel et al, 2012)]. T140, the peptidic CXCR4 antagonist, resulted in a statistically eloquent reduction in pulmonary metastasis of MDA-MB-231 in severe combined immunodeficiency (SCID) mice (Tamamura et al, 2003).…”
Section: Introductionmentioning
confidence: 99%
“…Abnormal expression of chemokines or their receptors is positively correlated with the development, progression and metastasis of tumor cells ( 3 , 4 ). CXC chemokine receptor-4 (CXCR4) is highly expressed on the surface of several different types of tumors ( 5 ). CXCL12 (CXC motif chemokine 12) [also known as stromal cell-derived factor (SDF-1)] has been identified as the specific ligand of CXCR4 and it is likely that the CXCR4/CXCL12 axis is involved in the development, progression and metastasis of tumors ( 6 , 7 ).…”
Section: Introductionmentioning
confidence: 99%